Skip to main content

Find Clinical Trials

Home
Conditions
Nasopharyngeal Diseases

Clinical trial condition

Nasopharyngeal Diseases

Explore clinical trials studying Nasopharyngeal Diseases. Study availability and eligibility vary by location and protocol.

489 public trials 162 recruiting studies

Refine in advanced search Browse all conditions

Nasopharyngeal Diseases trial results

Recruiting

Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma

NCT06277050

Conditions: Carcinoma, Head and Neck Neoplasms, High-Risk Cancer, +13 more
Locations: Ganzhou Cancer Hospital Ganzhou, Jiangxi, China

First Affiliated hospital of Gannan Medical University Guangzhou, Jiangxi, China

Department of Nasopharyngeal Carcinoma, Jiangxi Cancer Hospital Nanchang, None Selected, China

View Trial Details

Recruiting

Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors

NCT07584499

Conditions: Atypical Teratoid/Rhabdoid Tumors, Carcinoma, Carcinoma, Squamous Cell, +53 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

NCT07038343

Conditions: Biliary Tract Cancer (BTC), Biliary Tract Diseases, Biliary Tract Neoplasms, +34 more
Locations: Avenzo Therapeutics Recruiting Site Gilbert, Arizona, United States

Avenzo Therapeutics Recruiting Site Los Angeles, California, United States

Avenzo Therapeutics Recruiting Site Denver, Colorado, United States

Avenzo Therapeutics Recruiting Site New Haven, Connecticut, United States

View all 18 locations

View Trial Details

Recruiting

CD70-targeted immunoPET Imaging of Malignant Cancers

NCT06852638

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +37 more
Locations: Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, China

View Trial Details

Recruiting

Sintilimab Combined With Anlotinib and Taxane-Based Chemotherap for Recurrent/Metastatic Nasopharyngeal Carcinoma

NCT07581821

Conditions: Carcinoma, Disease Attributes, Head and Neck Neoplasms, +18 more
Locations: Fifth Affiliated Hospital of Sun Yat-sen University Zhuhai, Guangdong, China, 519000 Zhuhai, Guangdong, China

View Trial Details

Recruiting

Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition

NCT04436965

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC

NCT06197776

Conditions: Carcinoma, Disease Attributes, Efficacy of Chemoradiotherapy and Immunotherapy, +18 more
Locations: Cancer Center, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial

NCT05340491

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

Peking University Third Hospital Beijing, China

Sichuan Cancer Hospital Chengdu, China

Fujian Province Cancer Hospital Fuzhou, China

View Trial Details

Recruiting

SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma

NCT06323239

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma

NCT06802835

Conditions: Carcinoma, Head and Neck Neoplasms, Metastatic Nasopharyngeal Carcinoma, +14 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details